Dorayshield recently announced the successful export of a batch of PET tungsten syringe shields to a medical research center in Egypt. This marks another significant breakthrough for Dorayshield’s nuclear medicine radiation protection products in the Egyptian market, underscoring the company's expanding business footprint across Africa.
The exported PET tungsten syringe shields are specifically designed for PET (Positron Emission Tomography) radionuclide injection procedures. Compatible with standard clinical PET syringes, they effectively shield against the 511 keV high-energy gamma rays emitted by positron-emitting radionuclides such as F-18 and Ga-68. Manufactured from high-density tungsten alloy, the shields offer a compact size and manageable weight while maintaining superior protective performance, allowing for convenient one-handed operation by medical staff. The high density of tungsten alloy—far exceeding that of traditional lead—enables effective radiation attenuation with thinner walls, balancing safety with ease of use.
The product features a screw-lock mechanism that securely fastens the syringe within the shield via manual rotation, effectively preventing loosening or shifting during injection and ensuring safe, reliable operation. The shield body undergoes precision machining and surface polishing, resulting in a smooth, easy-to-clean finish that withstands repeated wiping with standard disinfectants like alcohol, fully complying with infection control standards in medical environments. Optimized designs at both the front and rear ends ensure smooth needle protrusion while providing adequate protection for the operator's hands.
Egypt is a leader in nuclear medicine development within Africa and the Middle East. In recent years, the country has steadily increased investment in the field; numerous medical research centers have adopted advanced PET/CT equipment, leading to continuous improvements in clinical diagnostic capabilities and scientific research standards. As nuclear medicine applications become increasingly widespread, the demand for high-quality radiation protection products has grown. Dorayshield’s successful entry into this Egyptian medical research center reflects the client's high regard for the company's technical expertise and product quality.
Dorayshield has long specialized in the field of nuclear medicine radiation protection, establishing a comprehensive product line that covers various stages, including injection shielding, dose dispensing, and storage and transport. The company possesses end-to-end manufacturing capabilities—spanning material R&D, precision machining, and quality inspection—and exports its products to numerous countries and regions across Europe, the Middle East, and Africa. The company consistently upholds the philosophy of "safety as the foundation and quality first," providing safe and reliable radiation protection solutions for clinical nuclear medicine operations worldwide.
